Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

256
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
256
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

126
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
126
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

364
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
364
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

39
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
39
Confounding in Epidemiological Studies01:27

Confounding in Epidemiological Studies

169
Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
169
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

13.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exogenous creatine supplementation promotes tumor metastasis via megakaryocyte creatine kinase B-STAT5B signaling.

Nature communications·2026
Same author

Bypassing Pre-Photoactivation in High-Barrier Polyamide for Robust and Scalable Organic Persistent Luminescence.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

The gastrin-releasing peptide receptor in oncology: a comprehensive review of recent advances in targeted radionuclide theranostics.

Frontiers in oncology·2026
Same author

Letrozole Alters Transcriptomic Profiles in Infrapatellar Fat Pad From Female Mice: Possible Involvement of Interleukins in Aromatase Inhibitor-Induced Arthralgias.

Journal of applied toxicology : JAT·2026
Same author

Regulating surface oxygen species on activated carbon <i>via</i> plasma treatment to boost zinc-ion adsorption for zinc-ion hybrid capacitors.

Nanoscale horizons·2026
Same author

A Phase 1 Study to Assess the Relative Bioavailability of Brigatinib Administered as an Oral Solution Versus an Immediate-Release Tablet in Healthy Adults.

Clinical pharmacology in drug development·2026

Related Experiment Video

Updated: Jun 29, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.5K

Covariate adjusted meta-analytic predictive (CA-MAP) prior for historical borrowing using patient-level data.

Bradley Hupf1, Yunlong Yang2, Ryan Gryder1

  • 1Takeda Pharmaceuticals, Cambridge, MA, United States.

Journal of Biopharmaceutical Statistics
|April 2, 2024
PubMed
Summary

This study introduces a novel covariate adjusted meta-analytic-predictive (CA-MAP) prior for historical control borrowing in drug development. The method enhances borrowing by focusing on covariate effect similarity, not just outcome similarity, to overcome trial heterogeneity.

Keywords:
Covariate adjustedhistorical data borrowingmeta-analytic-predictivepatient level data

More Related Videos

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.1K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.7K

Related Experiment Videos

Last Updated: Jun 29, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.5K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.1K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.7K

Area of Science:

  • Biostatistics
  • Pharmacometrics
  • Clinical Trial Design

Background:

  • Historical data utilization in drug development is growing for efficiency.
  • Between-trial heterogeneity poses a significant challenge to standardizing historical data borrowing methods.
  • Existing methods often discount historical data based on outcome similarity, which can be misleading due to intrinsic trial variations.

Purpose of the Study:

  • To propose a novel covariate adjusted meta-analytic-predictive (CA-MAP) prior for historical control borrowing.
  • To address the limitations of current methods in handling between-trial heterogeneity and covariate distribution differences.
  • To enable more effective borrowing of historical data by focusing on covariate effect consistency.

Main Methods:

  • Development of a CA-MAP prior that assigns a MAP prior to each covariate effect.
  • Modeling covariate effects directly to determine the amount of information borrowed.
  • Integrating between-trial heterogeneity with covariate-level heterogeneity to fine-tune historical data borrowing.

Main Results:

  • The CA-MAP prior allows borrowing to be determined by the consistency of covariate effects across historical and current data.
  • The method effectively handles scenarios where population-level outcome summaries differ but covariate effects remain consistent.
  • This approach offers a unique way to leverage historical data by modeling covariate effects directly.

Conclusions:

  • The proposed patient-level extension of the MAP prior provides a robust method for historical control borrowing.
  • Borrowing effectiveness is enhanced by basing it on the similarity of covariate effects rather than clinical outcomes.
  • This facilitates more reliable and efficient use of historical data in drug development decision-making.